Introduction
The obesity market is easily characterized as attractive, featuring a booming patient potential needing long term therapy, but repeated product withdrawals and failed pipeline candidates highlight the reality of increasingly cautious regulatory bodies, reluctant payers, and a clinical community that puts more stock in diet and exercise: $513.7m sales in 2008 fall far short of analyst predictions.
Reasons to Purchase
*Understand why predictions for this market have been repeatedly over-stated
*Qualify market expectations against the practicalities of targeting this unyielding market
*Assess the qualities of marketed and pipeline products and their commercial handling to determine their realistic prospects
Other selected research from the 'Markets' category:
The Biofuels Market 2010-2020
The Biofuels Market 2010-2020 is our brand new renewable energy report which outlines trends in the flourishing biofuels industry and anticipates the direction of the market over the next decade... Learn More
Insomnia Market Forecast
The availability of generic versions of Ambien (zolpidem, Sanofi-Aventis) in the US from April 2007 onwards has intensified competition for both existing and prospective players in the insomnia market... Learn More
Other selected research from the 'Metabolic disorders' category:
Stakeholder Insight: Diabetes
Type 2 diabetes is an emerging epidemic driven by the escalating prevalence of obesity and by an ageing population. Diagnosis rates will continue to increase as improved awareness raises the public profile of the disease. Despite several established classes of oral anti-diabetic agents an unmet need for a safe, efficacious agent which can halt or reverse long-term disease progression remains. Learn More
Strategic Perspectives: Antidyslipidemics Current market is not conducive for growth
Analysis of the competitive landscape and the recent changes in antidyslipidemics across seven major markets. Explores the key events that are likely to impact the performance of the antidyslipidemics in detail. Learn More